|
Professional Practice
|
N04.452.758 |
|
|
Lapatinib
|
D000077341 |
[A quinazoline derivative that inhibits EPIDERMAL GROWTH FACTOR RECEPTOR and HER2 (RECEPTOR, ERBB-2) tyrosine kinases. It is used for the treatment of advanced or metastatic breast cancer, where tumors overexpress HER2.
] |
|
Post-Lyme Disease Syndrome
|
D000077342 |
[A subjective syndrome that occurs following standard antibiotic treatment of Lyme disease. It includes FATIGUE; MUSCULOSKELETAL PAIN; and neurocognitive dysfunction.
, A condition caused by long-lasting and ongoing infection with the spirochete Borrelia burgdorferi resulting in progressive inflammatory neurologic, neuromuscular, and dermatologic manifestations including ENCEPHALITIS; MYELITIS; acrodermatitis chronica atrophicans; and ARTHRITIS.
] |
|
Receptor-Like Protein Tyrosine Phosphatases, Class 1
|
D08.811.277.352.650.775.400.100 |
|
|
Isoxsuprine
|
D02.092.471.683.560 |
|
|
Adaptor Proteins, Vesicular Transport
|
D12.776.543.990.150 |
|
|
Middle East
|
Z01.252.245.500 |
|
|
Filipendula
|
B01.650.940.800.575.912.250.859.937.500.244 |
|
|
Prescription Drug Monitoring Programs
|
E05.337.800.800 |
|
|
Azulenes
|
D04.615.133 |
|
|
Positron Emission Tomography Computed Tomography
|
E01.370.350.710.800.399.500 |
|
|
Positron-Emission Tomography
|
E01.370.350.710.800.399 |
|
|
Butylated Hydroxyanisole
|
D02.355.726.158.324 |
|
|
Folate Receptors, GPI-Anchored
|
D12.776.543.484.500.370 |
|
|
Singapore
|
Z01.252.145.774 |
|
|
Letrozole
|
D02.626.300 |
|
|
Brain Abscess
|
C01.830.025.160 |
|
|
Calliphoridae
|
B01.050.500.131.617.720.500.500.750.155 |
|
|
Diptera
|
B01.050.500.131.617.720.500.500.750 |
|
|
Oral Health
|
D009909 |
[The optimal state of the mouth and normal functioning of the organs of the mouth without evidence of disease.
] |
